(Reuters) - British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued heartburn drug Zantac caused cancer. GSK does not admit to any ...
Combined with Yubico’s excellent onboarding materials and customer support, this key is the best one for those seeking an easy-to-use security key to protect their online accounts. The Yubico ...
Zantac was once a widely used medication for heartburn and stomach ulcers before concerns about potential carcinogens led to a market recall. The legal developments around ranitidine have been ...
GSK reached a settlement with plaintiff Isaac Dixon, resolving a case related to its discontinued heartburn medicine Zantac allegedly causing prostate cancer, filed in Illinois State court.
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...